June 9, 2026 Woman with advanced Alzheimer's regained speech and memories after taking magic mushrooms A woman with advanced Alzheimer's reportedly showed significant brain function improvements after taking psilocybin mushrooms, per a case report.
June 4, 2026 Ultra-processed foods linked to dementia risk Amen Clinics Associate Medical Director Dr. Eboni Cornish discusses a study linking ultra-processed foods to a higher dementia risk and cognitive decline.
June 1, 2026 One common activity may help detect dementia before diagnosis Scientists have discovered that a simple writing test could detect cognitive impairment in older adults before more serious symptoms develop.
June 1, 2026 Everyday task may help detect early dementia signs before diagnosis, study finds Scientists have discovered that a simple writing test could detect cognitive impairment in older adults before more serious symptoms develop.
May 25, 2026 One type of sitting may pose greater dementia risk than another, study suggests New research suggests the type of sitting matters for dementia risk, with mentally engaging activities linked to a significant reduction in risk.
May 25, 2026 Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say Researchers say an experimental Alzheimer's drug may calm brain inflammation linked to alcohol withdrawal, potentially reducing relapse and neural damage.
May 23, 2026 The 'age' of your blood could predict dementia risk, new study suggests A new study published by the Alzheimer's Association links biological age measured through blood metabolites to increased all-cause dementia risk.
May 21, 2026 NEWT GINGRICH: Alzheimer’s is waging a war on millions. Congress could help us win it Early detection of Alzheimer's disease through tau protein blood tests could delay dementia, but Medicare coverage policies create major barriers.
May 19, 2026 'Longevity gene' may protect the brain from Alzheimer's by boosting DNA repair, study finds A new study suggests the APOE2 longevity gene may protect the brain from Alzheimer's by helping neurons repair DNA damage and resist cell aging.
May 12, 2026 New option available for Alzheimer’s patients as FDA approves expanded drug use The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.